Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform
Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...
Stocktwits on MSN1d
Hims & Hers Adds Eli Lilly's Zepbound To Weight-Loss Offerings: Retail Excited Despite BofA Seeing 'Immaterial' Sales Impact
Shares of Hims & Hers Health Inc. ended Tuesday over 5% higher, lifting retail investor mood after the telehealth company ...
Pharmaceutical Commerce1d
Hims & Hers Begins Selling Zepbound
The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...
Physician's Weekly14h
Zepbound Now Available Through Hims AND Hers
The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.
Hims & Hers to sell Lilly’s Zepbound
Hims shares gained as much as 14% in New York, their biggest gain since Feb. 19.
pharmaphorum1d
Lilly adds another sales channel for obesity drug Zepbound
Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...
Hims & Hers to sell Zepbound through telehealth platform, Bloomberg reports
EDT Hims & Hers to sell Zepbound through telehealth platform, Bloomberg reportsDon't Miss Our End of Quarter Offers: Discover the ...
Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs
Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...